Nuix (ASX:NXL) share price hits all-time low: Time to buy?

Analytics software maker's stock price has almost halved in just a few days. Is it time to grab or has the company fundamentally changed?

| More on:
discount asx share price represented by words 50% crashing into ground

Image Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Nuix Ltd (ASX: NXL) shares sank to an all-time low of $5.70 during intraday trade on Wednesday.

The Nuix share price actually fell off a cliff back on Friday when the analytics software provider announced its financial results before the ASX opened for trade.

The 4% decline in revenue and statutory net loss of $16.6 million didn't impress the market, which felt the company was falling behind its own prospectus projections.

After trading at as high as $11.86 in January, Nuix shares fell an ugly 31% that day to go from $8.98 to $6.20.

And the Nuix share price has descended even further this week to trade in the $5s by Wednesday lunchtime.

So what happened to the market darling that listed on the ASX with much fanfare in early December?

Two experts back then picked Nuix as the best initial public offering (IPO) of 2020.

Now The Motley Fool has gone back to the same fund managers to see if their opinion has changed:

Nuix is a cheap technology share

Tribeca Investment Partners' Alpha Plus portfolio manager Jun Bei Liu still has faith in Nuix.

"Our view of the stock remains positive. We believe the share price has been severely punished on small changes in revenue composition."

She told The Motley Fool the Nuix share price is expected to head back up as the full-year results are delivered in August.

"This business is one of the cheapest tech businesses listed on the ASX. It's trading at half of the revenue multiple as many major tech businesses, [but] with higher growth."

Prime Value portfolio manager Richard Ivers is also still a believer.

"Long term it's still an attractive business," he told The Motley Fool.

"We didn't get a great allocation in the IPO and didn't chase the stock when it listed. So [we] haven't owned it the last few months – still watching."

Reasons for Nuix's poor half-yearly result

Ivers acknowledged the first-half result was "disappointing".

"The issue we are working to understand is the earnings profile and therefore the valuation of the business."

Liu said that two factors had contributed to the half-year results coming in poorer than the prospectus revenue forecast.

"Firstly, the Australian currency has strengthened against the US dollar — and a big part of Nuix's revenue is in US dollars," she said.

"Secondly, the US election in November last year has disrupted the timing of contract awards (many of those missed contracts have now been signed in January). If you adjust for these two factors, the revenue was largely in line with forecasts."

Only a couple of days before the half-yearly results, Morgan Stanley had put an overweight rating and a share price target of $11.00 on Nuix shares.

Tony Yoo owns shares of Nuix Pty Ltd. The Motley Fool Australia's parent company Motley Fool Holdings Inc. recommends Nuix Pty Ltd. The Motley Fool Australia has recommended Nuix Pty Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a happy end to the trading week this Friday.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A business person directs a pointed finger upwards on a rising arrow on a bar graph.
Share Gainers

3 ASX 200 stocks storming higher in this week's sinking market

Investors have sent these three ASX 200 stocks soaring this week. But why?

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Market News

Why Aeris Resources, Netwealth, Nova Minerals, and Paragon Care shares are dropping today

These shares are under pressure on Friday. Let's find out why.

Read more »

Two smiling work colleagues discuss an investment at their office.
Share Gainers

Why 4DMedical, Develop Global, EOS, and Maas shares are racing higher today

These shares are ending the week on a high. But why?

Read more »

A man leans forward over his phone in his hands with a satisfied smirk on his face although he has just learned something pleasing or received some satisfying news.
Share Market News

Downer EDI wins $870m NZ highway maintenance contracts: What investors need to know

Downer EDI wins major New Zealand state highway maintenance contracts worth NZ$870 million, expanding its infrastructure portfolio.

Read more »

A young woman lifts her red glasses with one hand as she takes a closer look at news about interest rates rising and one expert's surprising recommendation as to which ASX shares to buy
Broker Notes

Ord Minnett names 2 ASX 200 shares to buy for massive returns

The broker sees a lot of value in these big names. Here's what it is recommending.

Read more »

Six smiling health workers pose for a selfie.
Healthcare Shares

Up 657% in a year, 4DMedcial shares rocketing another 20% today on big US news

ASX investors can’t get enough of 4DMedical shares today. Let’s see why.

Read more »